US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.57

+0.07000.29%

Volume:16.50K

Turnover:402.98K

Market Cap:57.00M

PE:- -

High:24.57

Open:24.35

Low:24.35

Close:24.50

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.55

T/O Rate:0.71%

Dividend:1.71

Dividend Rate:6.94%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System

MT Newswires Live

Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares

GH Research to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference

Evion Moves to Cancel Unpaid Placement Shares and Options

Vanadium Resources Plans Major Share and Option Placement on ASX

Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy

Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD

Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program

THOMSON REUTERS

Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval Comp360 Provider Training

THOMSON REUTERS

Compass Pathways Management Attends Investor Conference Fireside Chats in New York Week of Sept. 14

Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Compass Pathways Rises After One-Year Data for Psychedelic-Based Depression Drug

Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 Comp005 Trial Demonstrates Additional Benefit from Another Comp360 Dose in Part C Extending Durability Out to 1 Year

THOMSON REUTERS

Compass Pathways - Rolling Nda Submission Underway; Final Submission on Track for Q4

THOMSON REUTERS

Compass Pathways - Continue to Expect Commercial Launch in H1 2027

THOMSON REUTERS

Compass Pathways - Comp360 Safety Profile in Part C Consistent with Prior Parts; no New Safety Findings

THOMSON REUTERS

Compass Pathways - 25 Mg Arm Shows Average 13-Point Madrs Reduction at Week 52 with Durability to 1 Year

THOMSON REUTERS

Aureka launches placement and share purchase plan to fund mine expansion and exploration

Structure weakness ‘disconnected’ from underlying data, says Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PSIL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.57,"timestamp":1789579795479,"preClose":24.5,"halted":0,"volume":16501,"delay":0,"changeRate":0.002857142857142869,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Trading","change":0.07,"latestTime":"09-16 13:32:12 EDT","open":24.35,"high":24.57,"low":24.35,"amount":402976.333328,"amplitude":0.00898,"askPrice":24.91,"askSize":1100,"bidPrice":24.58,"bidSize":4,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":24.5,"sharesOutstanding":1184976,"nav":25.051,"aum":58118072.21,"dividendRate":0.069402,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.06,"preClose":24.5,"latestTime":"08:44 EDT","volume":39,"amount":972.7199820000001,"timestamp":1789562657590,"change":0.56,"changeRate":0.022857,"amplitude":0.039592},"postHourTrading":{"tag":"盘后","latestPrice":25.52,"preClose":24.5,"latestTime":"19:30 EDT","volume":168,"amount":4296.44,"timestamp":1789515005327,"change":1.02,"changeRate":0.041633,"amplitude":0.041633},"volumeRatio":0.552502,"impliedVol":0.5194,"impliedVolPercentile":0.8725},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.552502,"shares":2319976,"dividePrice":1.7052,"high":24.57,"amplitude":0.00898,"preClose":24.5,"low":24.35,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.57,"committee":-0.992754,"eps":0,"divideRate":0.069402,"volume":16501,"delay":0,"ttmEps":0,"open":24.35,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":25.21,"twentyDayClose":26.2,"sixtyDayClose":21.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666892521","title":"NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System","url":"https://stock-news.laohu8.com/highlight/detail?id=2666892521","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666892521?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:32","pubTimestamp":1789126372,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals'  HOPE Therapeutics unit will deploy Zeta Surgical's TMS Robotic System in Florida, with its clinical staff already undergoing orientation and training, NRx said Friday.TMS is a non-invasive therapy mainly used for treatment-resistant depression, and the robotic system's deployment will support NRx's phase 2/3 trial of an NRX-101 combination therapy, the company said.Financial details of the deployment were not disclosed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PSIL","LENZ","BK4139","NRXP","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529085","title":"Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529085","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529085?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:30","pubTimestamp":1789126244,"startTime":"0","endTime":"0","summary":"Relmada CFO Maged Shenouda acquires $843,140 of common sharesRelmada Therapeutics CFO Maged Shenouda bought 200,000 common shares in open-market purchases at about $4.20–$4.25 each.His directly held s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL4WN5mf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666293255","title":"GH Research to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666293255","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666293255?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:01","pubTimestamp":1789124491,"startTime":"0","endTime":"0","summary":"GH Research to hold one-on-one investor meetings at Morgan Stanley Global Healthcare ConferenceGH Research will hold one-on-one investor meetings at the Morgan Stanley 24th Annual Global Healthcare Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9pJPZ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU0234570918.USD","LU1064131342.USD","LU2028103732.USD","BK4581","BK4127","LU2347655156.SGD","LU2357305700.SGD","LU1989772840.SGD","LU1720051108.HKD","LU0106831901.USD","GHRS","LU1989772923.USD","LU2271345857.HKD","LU0053666078.USD","PSIL","IE00BKVL7J92.USD","LU0882574139.USD","LU1244550577.SGD","IAI","IE00B775SV38.USD","LU1244550221.USD","LU0557290698.USD","BK4007","LU2264538146.SGD","BK4516","LU1244550494.USD","LU0225283273.USD","LU1791710400.SGD","LU0098860793.USD","IE00BZ1G4Q59.USD","LU0971096721.USD","BK4534","LU2089283258.USD","LU1363072403.SGD","LU0390134368.USD","LU0795875086.SGD","LU1074936037.SGD","LU2023251221.USD","LU0267386448.USD","BK4504","LU0314104364.USD","LU0158827781.USD","LU0320765646.SGD","IE00B3S45H60.SGD","LU0528227936.USD","LU1732799900.SGD","LU1548497426.USD","LU1732800096.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666548670","title":"Evion Moves to Cancel Unpaid Placement Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666548670","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666548670?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:22","pubTimestamp":1789096958,"startTime":"0","endTime":"0","summary":"BlackEarth Minerals NL ( ($AU:EVG) ) has shared an update. Evion Group NL has moved to unwind part of a recent capital raising after certain partic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evion-moves-to-cancel-unpaid-placement-shares-and-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evion-moves-to-cancel-unpaid-placement-shares-and-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVG","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666514254","title":"Vanadium Resources Plans Major Share and Option Placement on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2666514254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666514254?lang=en_us&edition=fundamental","pubTime":"2026-09-11 08:37","pubTimestamp":1789087034,"startTime":"0","endTime":"0","summary":"Vanadium Resources Ltd. ( ($AU:VR8) ) has provided an announcement. Vanadium Resources Ltd. has announced a proposed capital raising through the is...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vanadium-resources-plans-major-share-and-option-placement-on-asx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vanadium-resources-plans-major-share-and-option-placement-on-asx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659418","title":"Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659418?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:50","pubTimestamp":1789051821,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study initiation plans, a Breakth...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910405","title":"Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910405?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:25","pubTimestamp":1789050337,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announces plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for individuals with maj...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MEDX","OPTH","ABVC","BK4139","HYLG","NVIB","GDOC","PSIL","IDNA","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567022","title":"Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567022?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8WKBZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","FBT","IBRN","PSIL","PSCH","BK4139","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956780","title":"Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval Comp360 Provider Training","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666956780?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:35","pubTimestamp":1789036500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8YJNLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562043","title":"Compass Pathways Management Attends Investor Conference Fireside Chats in New York Week of Sept. 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562043?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:30","pubTimestamp":1789036255,"startTime":"0","endTime":"0","summary":"Compass Pathways management attends investor conference fireside chats in New York week of Sept. 14Compass Pathways management to join investor conferences in New York during the week of Sept. 14.Fire","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL86MRVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554185","title":"Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554185?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:05","pubTimestamp":1788998708,"startTime":"0","endTime":"0","summary":"Disc Medicine (IRON) “presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera. The dat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/disc-medicine-presents-initial-results-from-restore-phase-2-trial-in-pv-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/disc-medicine-presents-initial-results-from-restore-phase-2-trial-in-pv-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DISC","IRON","BK4139","BBC","PSIL","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535291","title":"U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535291","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535291?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:24","pubTimestamp":1788960267,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-UGI, Chewy, Cognyte SoftwareSeptember 9 (Reuters)-The main U.S. stock indexes were on course to open lower on Wednesday, when oil prices surged past the market-sensitive $","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL6N4510Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU1032466523.USD","LU2168564149.EUR","METD","LU0788109477.HKD","HK0000914660.USD","BK4592","IE00BFMHRM44.USD","IE0009G5SDU7.USD","RSPC","LU2065170008.USD","LU2250418816.HKD","LU2505996681.GBP","LU0552385451.USD","LU1778281490.HKD","LU1935042991.SGD","LU0345781412.USD","LU0006306889.USD","SG9999014914.USD","IE000M9KFDE8.USD","LU1852331112.SGD","SG9999004303.SGD","LU0215105999.USD","LU1629891620.HKD","LU2592432038.USD","GAMR","IE0004445239.USD","LU2746668461.USD","LU0266512127.USD","LU0820561909.HKD","FBX","BK4196","LU2430703251.USD","IE00BZ1G4Q59.USD","LU2237438978.USD","TH","IE00BSNM7G36.USD","LU2750360997.AUD","LU0310800379.SGD","LU0211331839.USD","LU0417517546.SGD","LU2764263039.SGD","BK4200","SG9999002521.SGD","LU1267930490.SGD","LU1935043023.USD","LU1670710661.SGD","LU1815333072.USD","LU1582986433.USD","LU0994945656.USD","CHWY","SG9999014575.USD","LU1699723380.USD","LU2552382132.HKD","IE00B5TLWC47.USD","META","LU0267386448.USD","FTXN","IE00BJJMRY28.SGD","BK4534","LU0098860793.USD","LU2317271919.USD","LU1571399168.USD","LU2065171311.SGD","SG9999017495.SGD","LU0061475181.USD","XOMX","LU1153585028.USD","LU1564329115.USD","IE0034235188.USD","LU0029864427.USD","LU1718418525.SGD","GB00B4LPDJ14.GBP","IE00BMPRXR70.SGD","LU2264538146.SGD","LU1280957306.USD","IE00BQXX3C00.GBP","FCG","LU1935043536.SGD","LU1992135472.HKD","LU2272731782.SGD","LU0889565833.HKD","LU0345770308.USD","IE00B775H168.HKD","LU0640476718.USD","LU1121112475.USD","LU0823421333.USD","LU2054465674.USD","LU1150488218.USD","LU2488822045.USD","SG9999018865.SGD","BK4516","LU2756315318.SGD","IE000MB6IJN5.SGD","IE00B19Z3B42.SGD","LU0072462426.USD","LU1429558221.USD","LU2063271972.USD","LU0719512351.SGD","LU1435385759.SGD","IE00B1BXHZ80.USD","LU0320765489.SGD","LU0466842654.USD","LU0683600562.USD","SGXZ51526630.SGD","LU1861220207.SGD","LU0345774391.USD","LU0612318385.USD","LU2552382058.USD","SOCL","IE00BKDWB100.SGD","BK4112","LU0130103400.USD","LU0203202063.USD","LU2487616109.SGD","LU0256331488.USD","LU1150488135.SGD","IE00B19Z9505.USD","LU1815336760.USD","LU0211328371.USD","LU1430594728.SGD","LU1861217088.USD","GXPE","LU0314104364.USD","LU2322448957.HKD","LU0976567544.SGD","LU2357627491.SGD","WLK","LU0964807845.USD","LU0859254822.USD","LU0070217475.USD","LU0868494617.USD","LU2361045086.USD","SG9999014906.USD","LU0128525689.USD","LU0072461881.USD","SG9999015986.USD","XOMZ","LU1861559042.SGD","LU0308772762.SGD","LU1839511570.USD","LU0792757196.USD","SG9999015358.SGD","LU0265550359.USD","LU0097036916.USD","LU2347655073.USD","VOX","LU2272731600.USD","BK4201","BK4550","IE00BMPRXN33.USD","LU0823434740.USD","LU1670710588.SGD","TTAN","IE00BJTD4N35.SGD","LU0058720904.USD","LU1116320901.HKD","METU","LU1059921491.USD","BK4007","LU1674673691.USD","BK4140","IE00BFXG1179.USD","LU1201861165.SGD","LU1564329032.USD","METQ","LU0162691827.USD","DRLL","LU0109391861.USD","LU1035773651.USD","LU0354030438.USD","LU0354030511.USD","LU2552382215.SGD","SIG","LU0052756011.USD","LU1868837300.USD","ASO","LU0642271901.SGD","LU0256863811.USD","LU0345774631.USD","LU2860962120.EUR","LU2430703095.HKD","LU0127658192.USD","BK4023","LU0130102774.USD","LU1868836914.USD","LU1201861249.SGD","LU2381873111.SGD","GXPC","BK4595","LU2896262040.SGD","BK4139","BK4543","BK4212","LU0266512473.USD","LU0726765562.USD","FBYY","LU0345769631.USD","IE00BK4W5M84.HKD","LU2458330243.SGD","LU0788109394.HKD","VTRS","TRUC","DOW","LU0878866978.SGD","LU1003077747.HKD","LU1267930573.SGD","IE00B4JS1V06.HKD","LU2168564222.USD","IE000WAW04H5.SGD","LU0433182093.SGD","LU2756315664.SGD","IE00B3SWFQ91.USD","TRUN","LU0949170772.SGD","LU1066051498.USD","SG9999015978.USD","IE0005OL40V9.USD","LU0154236417.USD","LU2242650005.HKD","LU0061474705.USD","LU1917777945.USD","LU2420271590.USD","LU0985489474.SGD","LFST","LU2404859741.USD","IE000KEQY171.SGD","LU1585245621.USD","LU0256863902.USD","LU1506573853.SGD","LU0070302665.USD","LU0708995401.HKD","LU0266013472.USD","LU1935042488.USD","GB00B4QBRK32.GBP","LTL","BK4142","LU0211326755.USD","LU0557290698.USD","LU1430597077.USD","LU2236285917.USD","LU0795875169.SGD","LU1935043452.HKD","IRT","LU0300736492.USD","IE00B19Z8X17.USD","LU0787776722.HKD","IE0001KFT4U8.USD","LU2750360641.GBP","LU0143551892.USD","IE000F7OJYX1.SGD","LU0348723411.USD","LU1791710400.SGD","BK4539","IE00BMPRXQ63.HKD","HK0000914686.HKD","LU1242518857.USD","LU0238689110.USD","SG9999014567.USD","LU2168564065.EUR","LU0096362180.USD","IE000SO60NU8.SGD","LU0980610538.SGD","LU0203347892.USD","UGI","LU0234572021.USD","SGXZ81514606.USD","XDAT","LU0661504455.SGD","LU1674673428.USD","LU0477156797.USD","FCOM","LU0316494557.USD","LU0738911758.USD","LU2471134952.CNY","LU0426412945.USD","LU2357305700.SGD","LU1366192091.USD","IE00BJJMRX11.SGD","CI","LU0203345920.USD","BK4559","CMPS","LU0096364046.USD","LU0198837287.USD","LU0061474960.USD","LU0545039389.USD","IE00B7SZLL34.SGD","VDE","LU0690374961.EUR","IE00BQXX3F31.USD","BKKT","LU1941712264.USD","LU0949170426.SGD","LU1267930730.SGD","LU0170899867.USD","XLE","IE00BKVL7J92.USD","BK4561","LU2265009873.SGD","SGXZ31699556.SGD","LU0054578231.USD","LU0077335932.USD","LU0082616367.USD","LU1267930227.SGD","SG9999014542.SGD","LU0979878070.USD","LU2087625088.SGD","LU0323591593.USD","IE000YTNTUN2.SGD","LU0068578508.USD","LU2361044865.SGD","SGXZ80539844.SGD","LU1066053197.SGD","ERX","IE00B1XK9C88.USD","LU1162221912.USD","LU1642822529.SGD","LU2764263203.CNY","LU2168564495.EUR","IE00BFSS8Q28.SGD","LU1489326972.SGD","SG9999015952.SGD","LU1582987324.SGD","LU0943347566.SGD","LU0786609619.USD","LU0648001328.SGD","LU0912757837.SGD","JILL","LU0234570918.USD","LU1791710582.SGD","LU0823421416.USD","LU2462591350.SGD","DIG","LU0265550946.USD","LU1119994496.HKD","LU2023250843.SGD","SG9999018857.SGD","LU1670711123.USD","CGNT","IE000BZT7R73.USD","COP","HK0000304797.USD","LU0689472784.USD","LU2461242641.AUD","TEXU","LU0314106906.USD","XOM","BK4090","LU1046421795.USD","LU0122376428.USD","LU0174119429.USD","LU1564329628.SGD","LU2102340556.USD","LU2746668974.SGD","LU1868836757.USD","PSIL","SMETAmain","BK4227","LU0053666078.USD","LU1861558580.USD","LU1868837136.USD","LU2129689514.USD","LU1127390331.HKD","LU0553294199.USD","IGE","LU2213496289.HKD","LU2404859667.USD","LU2247934214.USD","LU2360107671.USD","LU1043141123.HKD","LU2023250504.SGD","LU1069344957.HKD","LU0210528500.USD","LU2106854487.HKD","LU1169590202.USD","LU0345769128.USD","BK4548","BK4524","LU0289739699.SGD","LU2471134879.HKD","LU2097829019.USD","LU2322448791.USD","OGIG","LU2360032135.SGD","LU0648000940.SGD","LU2999663052.SGD","LU1035775433.USD","IE000ITXATA3.USD","SG9999001440.SGD","BK4104","LU0784385170.HKD","LU2602419157.SGD","LU2244417387.USD","LU0210536198.USD","BK4570","XOMO","WEEI","LU1084165304.USD","BK4581","LU2403377893.USD","LU1074936037.SGD","LU2133065610.SGD","LU0820561818.USD","LU1720051108.HKD","IE00BFSS7M15.SGD","LU2125154778.USD","LU0276348264.USD","LU0211326839.USD","LU0708994859.HKD","IE000W1ABFV2.USD","LU0210533765.USD","SG9999015341.SGD","LU0985320562.USD","LU0157215616.USD","LU1169589451.USD","LU2462611646.USD","LU1988902786.USD","LU0496365809.HKD","LU0368265418.SGD","LU0724617625.USD","LU2347655156.SGD","LU0278409577.USD","LU0444971666.USD","LU2473716301.USD","IE00B19Z3581.USD","LU0208291251.USD","LU1732799900.SGD","IE0004445015.USD","METV","LU0784384876.USD","LU1043141396.HKD","BPAY","LU1496350502.SGD","METW","IE0002270589.USD","LU2430703178.SGD","LU2456880835.USD","LU0654597011.USD","SGXZ99366536.SGD","LU2498475776.HKD","IE00BJLML261.HKD","LU1064131342.USD","LU2462591277.SGD","BK4535","LU2462157665.USD","LU1929549753.HKD","LU0690374615.EUR","LU1242518931.SGD","SG9999001077.SGD","LU1814569148.SGD","LU0476273544.USD","BK4213","LU1883866441.USD","LU0203201768.USD","LU0612318971.USD","LU2065171402.SGD","LU0080751232.USD","LU1235294995.USD","LU0130518102.USD","LU1069347547.HKD","SG9999002224.SGD","LU0345780950.USD","BK4583","EVMN","LU2065169927.USD","IE00B3CCJ963.GBP","BK4094","LU0957791311.USD","LU1992135399.USD","LU0672654240.SGD","LU1496350171.SGD","LU2463028550.USD","LU0820562030.AUD","LU0882574139.USD","LU1935042215.USD","BK4566","LU1316542783.SGD","BK4588","LU2471134523.USD","LU2087621335.USD","FBL","LU2023250330.USD","IE0009356076.USD","SUNB","LU1979441026.SGD","LU2272731865.HKD","IE00BQXX3D17.EUR","LU1582987597.SGD","BK4547","LU1145028129.USD","SG9999014559.SGD","IE00BK4W5L77.USD","IE00B2Q91V27.USD","LU1670711040.USD","LU0320765059.SGD","IE0000B7K699.USD","LU0225283273.USD","LU0345770993.USD","LU0823434583.USD","LU1670628061.USD","LU2471134796.USD","SMMT","LU0310799852.SGD","LU1804176565.USD","LU0456854461.SGD","LU1732800096.USD","BK4600","LU0011850046.USD","LU1582986359.USD","LU0942090050.USD","CHYM","SGXZ23171101.USD","FMED","SG9999014880.SGD","LU0353189763.USD","LU2168563687.JPY","OILT","LU0784385840.USD","BK4587","FBY","LU2543165471.USD","LU1366333091.USD","LU2764262908.HKD","TYRA","IE00B7KXQ091.USD","LU1301847155.USD","BK4122","LU0109392836.USD","LU0300736062.USD","LU0310800965.SGD","LU1564329461.SGD","IE00BGHQF524.EUR","LU2361044949.HKD","LU2125154935.USD","IE00BWXC8680.SGD","HK0000304805.HKD","LU1261432733.SGD","LU0079474960.USD","BKNU","BK4077","LU0353189680.USD","LU1551013342.USD","SG9999015945.SGD","LU1116320737.USD","LU1914381329.SGD","NULC","LU0133085943.USD","METG","FXG","LU1823568750.SGD","IE00BJTD4V19.USD","LU0106261372.USD","IE00B5949003.HKD","IEO","LU0187121727.USD","LU1894683264.USD","LU2505996509.AUD","LU0477156953.USD","LU0128525929.USD","LU0444973449.USD","IE0034235303.USD","LU2237957811.SGD","SG9999014898.SGD","LU0784383803.USD","BK4197","LU2720916845.USD","GB00BDT5M118.USD","BKNG","LU0149725797.USD","LU0889566641.SGD","IXC","LU0528227936.USD","LU1548497426.USD","SFD","LU1941712348.USD","LU1670627923.USD","LU0056508442.USD","LU0823411888.USD","LU2458330169.SGD","LU1803068979.SGD","LU0130517989.USD","LU1232071149.USD","IE00B4YYXB79.USD","BK4585","LU1974910355.USD","LU1989764664.SGD","OXY","LU0795875086.SGD","LU1868836591.USD","LU0868494708.USD","LU2360106780.USD","INGM","LU2326559502.SGD","LU1697837992.HKD","IYE","PAWZ","IE0003U64NQ7.SGD","LU2129689431.USD","LU0211327993.USD","BK4215","LU1551013425.SGD","LU2237957902.USD","FENY","IE00B19Z8W00.USD","LU2417539215.USD","WNDR","XLC","LU0630314457.HKD","LU2954938101.SGD","SG9999002232.USD","LU1267930813.SGD","LU1894683348.USD","CVX","IE00BN29S564.USD","LU0957808578.USD","BK4507","AWAY","LU0426417589.USD","LU2129689605.HKD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580430","title":"Compass Pathways Rises After One-Year Data for Psychedelic-Based Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580430","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580430?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:46","pubTimestamp":1788954365,"startTime":"0","endTime":"0","summary":"BUZZ-Compass Pathways rises after one-year data for psychedelic-based depression drug** Shares of Compass PathwaysCMPS.Orise 5.3% to $14.78 premarket** Co reports 52-week data from its late-stage trial showing that additional doses of its psychedelic-based treatment, COMP360, helped sustain reductions in depression symptoms in patients with treatment-resistant depression ** CMPS says patients who were initially assigned to the 25 mg COMP360 arm and received an additional dose in the open-label portion of the study showed an average 13-point reduction from baseline on a scale used to measure the severity of depressive episodes at week 52** Across all participants receiving a 25 mg dose during the open-label phase, response rates were 40%-45% and about 30% achieved remission during the six weeks after treatment** Compass says a rolling submission of its U.S. new drug application is underway, with final filing expected in Q4** It expects a potential commercial launch in H1 2027** As of la","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL4N4510ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584065","title":"Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 Comp005 Trial Demonstrates Additional Benefit from Another Comp360 Dose in Part C Extending Durability Out to 1 Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584065?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584051","title":"Compass Pathways - Rolling Nda Submission Underway; Final Submission on Track for Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584051?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584015","title":"Compass Pathways - Continue to Expect Commercial Launch in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584015?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458406","title":"Compass Pathways - Comp360 Safety Profile in Part C Consistent with Prior Parts; no New Safety Findings","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458406?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666054584","title":"Compass Pathways - 25 Mg Arm Shows Average 13-Point Madrs Reduction at Week 52 with Durability to 1 Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2666054584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666054584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666303585","title":"Aureka launches placement and share purchase plan to fund mine expansion and exploration","url":"https://stock-news.laohu8.com/highlight/detail?id=2666303585","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666303585?lang=en_us&edition=fundamental","pubTime":"2026-09-09 07:53","pubTimestamp":1788911605,"startTime":"0","endTime":"0","summary":"Aureka Limited ( ($AU:AKA) ) just unveiled an update. Aureka Limited has launched a capital raising initiative comprising a $5.65 million share pla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aureka-launches-placement-and-share-purchase-plan-to-fund-mine-expansion-and-exploration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aureka-launches-placement-and-share-purchase-plan-to-fund-mine-expansion-and-exploration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4094","BK4122","AKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXH","FHLC","BBP","BME","MRNY","SBIO","CANC","XPH","IEIH","PBPH","IBBQ","AZNH","PSIL","MDTX","PTH","HYLG","FXH","MNTL","IBBJ","FBT","IDNA","IBRN","CNCR","PBE","PINK","GNOM","LFSC","HRTS","NVIB","SURI","MEDI","BBH","PSCH","GDOC","GPCR","JHMH","GNMX","LLYX","BIB","CURE","MEDX","APXH","IBB","JDOC","RSPH","TBXU","WDNA","GSKH","PJP","SYNB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}